C

이노진

344860KOSDAQ기타 화학제품 제조업

54.0 / 100

Reference Date: 2026-04-13

Financial Score15.0 / 40
News Sentiment15.0 / 25
Momentum12.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Rose 7.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Inozen is a cosmeceutical company specializing in hair loss and problematic skin care, offering comprehensive solutions including home care, scalp devices, health supplements, and pharmaceuticals both domestically and internationally. In 2024, hair loss products accounted for 82% of sales, utilizing IIT (Initial Intensive Therapy) and DEDS (Different Etiology, Different Solution) systems for personalized treatment. Its skincare product line features mild, acidic pH formulations with soothing effects, under brands like Dr. Medition and Rescuvai.

Number of Employees

58people

Average Salary

40.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
60.38Industry Average 18.380.0Point

3.3x industry avg (risky)

PBR
1.34Industry Average 1.374.0Point

In line with industry avg

ROE
1.88Industry Average 4.551.0Point

Well below industry avg

Debt Ratio
0.13Industry Average 8.138.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼9.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼73.9% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 6.6% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 0Negative 0Average Sentiment Score 80

Detailed Momentum

52-week position1.0Point

Near 52w low (18%, downtrend)

Current 1,570Won52-week high 2,58552-week low 1,334
1-month return5.0Point

1m +7.09% (rising)

Volume trend6.0Point

Volume surge

Detailed Disclosure

6 totalPositive 1Neutral 5Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-08
  • Positive단일판매ㆍ공급계약체결(자율공시)2026-04-01
  • Neutral정기주주총회결과2026-03-26
  • Neutral기업가치제고계획(자율공시)2026-03-26
  • Neutral사업보고서 (2025.12)2026-03-17